Abortion With Self-Administered Misoprostol: A Guide For Women
Misoprostol as adjunct treatment for treatment of postpartum haemorrhage
Misoprostol as adjunct treatment for treatment of postpartum haemorrhage
Misoprostol for the Prevention of Postpartum Hemorrhage: Findings from Research in Pakistan
Increasing women's choices in medical abortion in Turkey
Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone
Increasing women's choices in medical abortion in Turkey
Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone
Increasing women's choices in medical abortion in Turkey
Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone
Methotrexate compared to misoprostol alone for early medical abortion
Improving Current Therapies and Exploring New Options in Abortifacient Technology
What measured blood loss tells us about postpartum bleeding
Ultrasound for eligibility assessment for medical abortion
Prevention of postpartum hemorrhage with misoprostol
Treatment of postpartum hemorrhage with misoprostol
Oral Misoprostol for the Management of Incomplete Abortion in Ecuador
Are two doses of misoprostol after mifepristone for early abortion better than one?
Mifepristone for late first trimester abortion
Knowledge, attitudes, and practice of abortion among women and doctors in Armenia
Ultrasound for eligibility assessment for medical abortion
Exploration of a new procedure for sterilization
Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1/2
High fever following postpartum administration of sublingual misoprostol
Misoprostol for incomplete abortion in Mozambique
Misoprostol to augment routine active management of the third stage of labor
Assessment of pregnancy duration among termination of pregnancy clients in South Africa
Integrating medical abortion into safe abortion services in South Africa
Self-induction of abortion among women in the United States
Misoprostol for incomplete abortion in Burkina Faso
Treatment of incomplete abortion and miscarriage with misoprostol
Prevention of postpartum hemorrhage with misoprostol
Treatment of postpartum hemorrhage with misoprostol
Misoprostol: A New Addition to Post Abortion Care
Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1/2
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2/2
What measured blood loss tells us about postpartum bleeding
Misoprostol as adjunct treatment for treatment of postpartum haemorrhage
Sublingual misoprostol vs. MVA for the treatment of incomplete abortion in Egypt
Oral misoprostol as an alternative to surgical management for incomplete abortion in Ghana
Misoprostol for PPH prevention in homebirths in Pakistan
Misoprostol to augment routine active management of the third stage of labor
Comparing two early medical abortion regimens: Mifepristone+misoprostol vs. misoprostol alone
Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-trimester Abortion
The supreme court and the partial-birth abortion ban act of 2003
Sublingual misoprostol for incomplete abortion
Alternatives to mifepristone for early medical abortion
Misoprostol to augment routine active management of the third stage of labor
Are two doses of misoprostol after mifepristone for early abortion better than one?
Mifepristone for late first trimester abortion
Perspectives on reproductive decision-making amongst HIV-infected individuals
Reproductive intentions among HIV-positive women and men
Route of Misoprostol Administration
Abortion and sex determination
Mifepristone medical abortion in Albania
Sublingual misoprostol after mifepristone
Acceptability and feasibility of medical abortion in Nepal
Home administration of misoprostol for early medical abortion in India
Alternatives to Routine Follow-Up for Early Medical Abortion
Ultrasound for eligibility assessment for medical abortion
Introduction and provision of medical abortion: A tale of two countries
Review of the Literature on Patient Satisfaction with Early Medical Abortion
Guidebook on Misoprostol for Treatment of Incomplete Abortion
High fever following postpartum administration of sublingual misoprostol
Self-induction of abortion among women in the United States
Misoprostol as adjunct treatment for treatment of postpartum haemorrhage
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2/2
Sublingual misoprostol vs. MVA for the treatment of incomplete abortion in Egypt
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1/2
Misoprostol for incomplete abortion in Mozambique
Knowledge, attitudes, and practice of abortion among women and doctors in Armenia
Use of sequential serum hCG and sonography for medical abortion only when indicated
Can mifepristone medical abortion be simplified?
Misoprostol for incomplete abortion in Tanzania
Misoprostol for uterine evacuation in induced abortion and pregnancy failure
Alternatives to Routine Follow-Up for Early Medical Abortion
Ultrasound for eligibility assessment for medical abortion
Sublingual misoprostol after mifepristone
Sublingual misoprostol for incomplete abortion
Buccal vs. sublingual misoprostol after mifepristone for medical abortion
Assessment of pregnancy duration among termination of pregnancy clients in South Africa
Perspectives on reproductive decision-making amongst HIV-infected individuals
Reproductive intentions among HIV-positive women and men
Integrating medical abortion into safe abortion services in South Africa
Are two doses of misoprostol after mifepristone for early abortion better than one?
Mifepristone for late first trimester abortion
Two distinct oral routes of misoprostol in mifepristone medical abortion
Two distinct oral routes of misoprostol in mifepristone medical abortion
Medical abortion: Outcomes in a family medicine setting
Assessment of pregnancy duration among termination of pregnancy clients in South Africa
Integrating medical abortion into safe abortion services in South Africa
Abortion in the Middle East and North Africa
Increasing women's choices in medical abortion in Turkey
Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1/2
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2/2
Sublingual misoprostol vs. MVA for the treatment of incomplete abortion in Egypt
Comparing two early medical abortion regimens: Mifepristone+misoprostol vs. misoprostol alone
Review of the Literature on Patient Satisfaction with Early Medical Abortion
Misoprostol for incomplete abortion in Burkina Faso
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2/2
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1/2
Sublingual misoprostol vs. MVA for the treatment of incomplete abortion in Egypt
Misoprostol for incomplete abortion in Mozambique
Assessment of pregnancy duration among termination of pregnancy clients in South Africa
Integrating medical abortion into safe abortion services in South Africa
Sublingual misoprostol after mifepristone
Buccal vs. sublingual misoprostol after mifepristone for medical abortion
Increasing women's choices in medical abortion in Turkey
Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2/2
Sublingual misoprostol for incomplete abortion
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2/2
Oral misoprostol as an alternative to surgical management for incomplete abortion in Ghana
Comparing two early medical abortion regimens: Mifepristone+misoprostol vs. misoprostol alone
Oral misoprostol as an alternative to surgical management for incomplete abortion in Ghana
Buccal vs. sublingual misoprostol after mifepristone for medical abortion
Increasing women's choices in medical abortion in Turkey
Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone
Regimens of misoprostol with mifepristone for early medical abortion
Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1/2
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2/2
High fever following postpartum administration of sublingual misoprostol
What measured blood loss tells us about postpartum bleeding
Misoprostol for PPH prevention in homebirths in Pakistan
Oral Misoprostol for the Management of Incomplete Abortion in Ecuador
Increasing women's choices in medical abortion in Turkey
Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone
Two distinct oral routes of misoprostol in mifepristone medical abortion
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2/2
Medical abortion: Outcomes in a family medicine setting
PPH Misoprostol Adjunct Treatment Study
Misoprostol PPH Treatment Study
Postpartum Hemorrhage: Responding to the Challenge
Postpartum Hemorrhage: A Challenge for Safe Motherhood
Blood Loss After Vaginal Delivery
Fever after treatment of postpartum hemorrhage
Misoprostol for the Prevention of Postpartum Hemorrhage: Findings from Research in Pakistan
Misoprostol for the Treatment of Postpartum Hemorrhage: Findings from Clinical Research Trials
Misoprostol to augment routine active management of the third stage of labor
Medical abortion: Outcomes in a family medicine setting
Home administration of misoprostol for early medical abortion in India
Sublingual misoprostol after mifepristone
Misoprostol to treat missed abortion in the first trimester
Medical abortion: Outcomes in a family medicine setting
Misoprostol to treat missed abortion in the first trimester
Treatment of incomplete abortion and miscarriage with misoprostol
Misoprostol to augment routine active management of the third stage of labor
Mifepristone medical abortion in Albania
Use of sequential serum hCG and sonography for medical abortion only when indicated
Can mifepristone medical abortion be simplified?
Self-induction of abortion among women in the United States
Two distinct oral routes of misoprostol in mifepristone medical abortion
Medical abortion for adolescents
Two distinct oral routes of misoprostol in mifepristone medical abortion
Can mifepristone medical abortion be simplified?
Self-induction of abortion among women in the United States
Regimens of misoprostol with mifepristone for early medical abortion
Pericoital Oral Contraception with Levonorgestrel: A Systematic Review
Route of Misoprostol Administration
FAQs on Fatal Infection and Medical Abortion - Summary
FAQs on Fatal Infection and Medical Abortion - Technical Version
Outlook Newsletter on Hormonal Contraception and HIV
Issue Brief on Hormonal Contraception and HIV
FAQ on Hormonal Contraception and HIV
Relationship of Hormonal Contraception to HIV
PAC in Action Newsletter: Special Issue on Misoprostol in the PAC Context
Misoprostol: A New Addition to Post Abortion Care
PPH Misoprostol Adjunct Treatment Study
Misoprostol PPH Treatment Study
Postpartum Hemorrhage: Responding to the Challenge
Postpartum Hemorrhage: A Challenge for Safe Motherhood
Reference List - Misoprostol for Prevention of Postpartum Hemorrhage
Misoprostol for Prevention of Postpartum Hemorrhage
Misoprostol and Teratogenicity: Reviewing the Evidence
Medical Abortion in the U.S.: Mifepristone Fact Sheet
Annotated Bibliography - Misoprostol for Early Abortion
Misoprostol for Early Abortion
PPH Prevention Study in Pakistan
Training and Education Activities Brief
PPH Treatment Study in Pakistan
Misoprostol for Incomplete Abortion and Miscarriage
Medical Abortion Program Brief
Postpartum Hemorrhage Program Brief
Pregnancy Failure and Miscarriage Program Brief
Materials Development Activities Brief
Policy and Advocacy Activities Brief
Social Science Research Activities Brief
Technical Assistance Activities Brief
STIs/ HIV/ Infectious Disease Program Brief
Blood Loss After Vaginal Delivery
Reference List - Misoprostol for Incomplete Abortion and Miscarriage
Fever after treatment of postpartum hemorrhage
Expanding Choice in Abortion Services in Armenia
Choices for Medical Abortion Introduction in Brazil, Colombia, Mexico and Peru
Improving Current Therapies and Exploring New Options in Abortifacient Technology
Abortion in the Middle East and North Africa
Misoprostol for the Prevention of Postpartum Hemorrhage: Findings from Research in Pakistan
Misoprostol for the Treatment of Postpartum Hemorrhage: Findings from Clinical Research Trials
Guidebook on Misoprostol for Treatment of Incomplete Abortion
Annotated Bibliography - Mifepristone Medical Abortion
Home administration of misoprostol for early medical abortion in India
Misoprostol, Abortion, and the Law
Abortion With Self-Administered Misoprostol: A Guide For Women
Misoprostol for Treatment of Postpartum Hemorrhage
Use of sequential serum hCG and sonography for medical abortion only when indicated
Perspectives on reproductive decision-making amongst HIV-infected individuals
Reproductive intentions among HIV-positive women and men
Integrating medical abortion into safe abortion services in South Africa
Introduction and provision of medical abortion: A tale of two countries
Misoprostol for PPH prevention in homebirths in Pakistan
Sublingual misoprostol vs. MVA for the treatment of incomplete abortion in Egypt
Misoprostol to treat missed abortion in the first trimester
Treatment of incomplete abortion and miscarriage with misoprostol
Self-induction of abortion among women in the United States
Misoprostol as adjunct treatment for treatment of postpartum haemorrhage
Misoprostol to augment routine active management of the third stage of labor
Two distinct oral routes of misoprostol in mifepristone medical abortion
Medical abortion: Outcomes in a family medicine setting
Issue Brief on Hormonal Contraception and HIV
Regimens of misoprostol with mifepristone for early medical abortion
Misoprostol for PPH prevention in homebirths in Pakistan
Misoprostol for incomplete abortion in Tanzania
Alternatives to mifepristone for early medical abortion
Acceptability and feasibility of medical abortion in Nepal
Mifepristone medical abortion in Albania
Integrating medical abortion into safe abortion services in South Africa
Misoprostol for incomplete abortion in Tanzania
Increasing women's choices in medical abortion in Turkey
Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone
Are two doses of misoprostol after mifepristone for early abortion better than one?
Acceptability and feasibility of medical abortion in Nepal
Misoprostol for incomplete abortion in Burkina Faso
Self-induction of abortion among women in the United States
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1/2
High fever following postpartum administration of sublingual misoprostol
Oral Misoprostol for the Management of Incomplete Abortion in Ecuador
Exploration of a new procedure for sterilization
Alternatives to Routine Follow-Up for Early Medical Abortion
Ultrasound for eligibility assessment for medical abortion
Pericoital Oral Contraception with Levonorgestrel: A Systematic Review
Misoprostol as adjunct treatment for treatment of postpartum haemorrhage
Acceptability and feasibility of medical abortion in Nepal
Are two doses of misoprostol after mifepristone for early abortion better than one?
Misoprostol to augment routine active management of the third stage of labor
Mifepristone medical abortion in Albania
Misoprostol for incomplete abortion in Tanzania
Assessment of pregnancy duration among termination of pregnancy clients in South Africa
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1/2
Misoprostol as adjunct treatment for treatment of postpartum haemorrhage
Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-trimester Abortion
Misoprostol for PPH prevention in homebirths in Pakistan
Mifepristone medical abortion in Albania
Oral Misoprostol for the Management of Incomplete Abortion in Ecuador
Alternatives to mifepristone for early medical abortion
Two distinct oral routes of misoprostol in mifepristone medical abortion
Misoprostol to augment routine active management of the third stage of labor
Perspectives on reproductive decision-making amongst HIV-infected individuals
Reproductive intentions among HIV-positive women and men
Comparing two early medical abortion regimens: Mifepristone+misoprostol vs. misoprostol alone
Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-trimester Abortion
Mifepristone for late first trimester abortion
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1/2
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2/2
Misoprostol as adjunct treatment for treatment of postpartum haemorrhage
Comparing two early medical abortion regimens: Mifepristone+misoprostol vs. misoprostol alone
Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-trimester Abortion
Abortion and sex determination
Perspectives on reproductive decision-making amongst HIV-infected individuals
Reproductive intentions among HIV-positive women and men
Misoprostol for incomplete abortion in Burkina Faso
Use of sequential serum hCG and sonography for medical abortion only when indicated
Outlook Newsletter on Hormonal Contraception and HIV
Self-induction of abortion among women in the United States
Oral Misoprostol for the Management of Incomplete Abortion in Ecuador
Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-trimester Abortion
Misoprostol and Teratogenicity: Reviewing the Evidence
Oral Misoprostol for the Management of Incomplete Abortion in Ecuador
Acceptability and feasibility of medical abortion in Nepal
Misoprostol for Women's Health
Misoprostol and Teratogenicity: Reviewing the Evidence
Abortion in the Middle East and North Africa
PAC in Action Newsletter: Special Issue on Misoprostol in the PAC Context
Two distinct oral routes of misoprostol in mifepristone medical abortion
Medical abortion: Outcomes in a family medicine setting
Misoprostol for incomplete abortion in Burkina Faso
Sublingual misoprostol after mifepristone
Sublingual misoprostol for incomplete abortion
Guidebook on Misoprostol for Treatment of Incomplete Abortion
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1/2
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2/2
Buccal vs. sublingual misoprostol after mifepristone for medical abortion
Comparing two early medical abortion regimens: Mifepristone+misoprostol vs. misoprostol alone
Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-trimester Abortion
Review of the Literature on Patient Satisfaction with Early Medical Abortion
Sublingual misoprostol for incomplete abortion
Exploration of a new procedure for sterilization
Are two doses of misoprostol after mifepristone for early abortion better than one?
Pericoital Oral Contraception with Levonorgestrel: A Systematic Review
Exploration of a new procedure for sterilization
Medical abortion for adolescents
FAQs on Fatal Infection and Medical Abortion - Summary
Issue Brief on Hormonal Contraception and HIV
Medical Abortion in the U.S.: Mifepristone Fact Sheet
Misoprostol for Early Abortion
Misoprostol for Incomplete Abortion and Miscarriage
Misoprostol, Abortion, and the Law
Abortion in the Middle East and North Africa
Mifepristone for late first trimester abortion
Treatment of incomplete abortion and miscarriage with misoprostol
Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-trimester Abortion
Alternatives to Routine Follow-Up for Early Medical Abortion
Ultrasound for eligibility assessment for medical abortion
Misoprostol for Women's Health
Misoprostol and Teratogenicity: Reviewing the Evidence
Supervision for use of mifepristone medical abortion
Misoprostol for uterine evacuation in induced abortion and pregnancy failure
Two distinct oral routes of misoprostol in mifepristone medical abortion
Comment on Misoprostol impairs female reproductive tract innate immunity against C. sordellii
Regimens of misoprostol with mifepristone for early medical abortion
Mifepristone medical abortion in Albania
Unsafe Abortion and Strategies to Reduce its Impact on Women’s Lives
Medical abortion: Outcomes in a family medicine setting
Exploration of a new procedure for sterilization
Regimens of misoprostol with mifepristone for early medical abortion
Misoprostol for incomplete abortion in Tanzania
Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan
Misoprostol as adjunct treatment for treatment of postpartum haemorrhage
Misoprostol to augment routine active management of the third stage of labor
Exploration of a new procedure for sterilization
Non-physician clinicians can safely provide first trimester medical abortion
Comparison of serum markers for thrombophilia and autoimmune disease
Review of the Literature on Patient Satisfaction with Early Medical Abortion
Alternatives to Routine Follow-Up for Early Medical Abortion
Ultrasound for eligibility assessment for medical abortion
Mifepristone medical abortion in Albania
Mifepristone medical abortion in Albania
Oral misoprostol as an alternative to surgical management for incomplete abortion in Ghana
Misoprostol as adjunct treatment for treatment of postpartum haemorrhage
Misoprostol for incomplete abortion in Burkina Faso
Misoprostol as adjunct treatment for treatment of postpartum haemorrhage
Knowledge, attitudes, and practice of abortion among women and doctors in Armenia
Buccal vs. sublingual misoprostol after mifepristone for medical abortion
Sublingual misoprostol after mifepristone
Buccal vs. sublingual misoprostol after mifepristone for medical abortion
Misoprostol for incomplete abortion in Mozambique
Assessment of pregnancy duration among termination of pregnancy clients in South Africa
Knowledge, attitudes, and practice of abortion among women and doctors in Armenia
Home administration of misoprostol for early medical abortion in India
Self-induction of abortion among women in the United States
Assessment of pregnancy duration among termination of pregnancy clients in South Africa
Integrating medical abortion into safe abortion services in South Africa
Prevention of postpartum hemorrhage with misoprostol
Treatment of postpartum hemorrhage with misoprostol
Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan
Misoprostol for PPH prevention in homebirths in Pakistan
Misoprostol for PPH prevention in homebirths in Pakistan
Misoprostol to treat missed abortion in the first trimester
Treatment of incomplete abortion and miscarriage with misoprostol
Prevention of postpartum hemorrhage with misoprostol
Treatment of postpartum hemorrhage with misoprostol
Mifepristone for late first trimester abortion
Misoprostol for incomplete abortion in Mozambique
Misoprostol for incomplete abortion in Tanzania
Misoprostol: A New Addition to Post Abortion Care
Comparison of serum markers for thrombophilia and autoimmune disease
Misoprostol as adjunct treatment for treatment of postpartum haemorrhage
Alternatives to mifepristone for early medical abortion
Regimens of misoprostol with mifepristone for early medical abortion
Are two doses of misoprostol after mifepristone for early abortion better than one?
Can mifepristone medical abortion be simplified?
Mifepristone for late first trimester abortion
Assessment of pregnancy duration among termination of pregnancy clients in South Africa
Methotrexate compared to misoprostol alone for early medical abortion
The supreme court and the partial-birth abortion ban act of 2003
Misoprostol for incomplete abortion in Mozambique
Misoprostol for incomplete abortion in Burkina Faso
Misoprostol for incomplete abortion in Tanzania
Misoprostol to treat missed abortion in the first trimester
Treatment of incomplete abortion and miscarriage with misoprostol
Prevention of postpartum hemorrhage with misoprostol
Treatment of postpartum hemorrhage with misoprostol
Misoprostol for Women's Health
Supervision for use of mifepristone medical abortion
Alternatives to mifepristone for early medical abortion
Misoprostol for uterine evacuation in induced abortion and pregnancy failure
Two distinct oral routes of misoprostol in mifepristone medical abortion
Comment on Misoprostol impairs female reproductive tract innate immunity against C. sordellii
Integrating medical abortion into safe abortion services in South Africa
Clostridium sordellii infection in medical abortion
Regimens of misoprostol with mifepristone for early medical abortion
Mifepristone medical abortion in Albania
Misoprostol and Teratogenicity: Reviewing the Evidence
Sublingual misoprostol after mifepristone
Sublingual misoprostol for incomplete abortion
Increasing women's choices in medical abortion in Turkey
Non-physician clinicians can safely provide first trimester medical abortion
Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone
Knowledge, attitudes, and practice of abortion among women and doctors in Armenia
Acceptability and feasibility of medical abortion in Nepal
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1/2
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2/2
Alternatives to Routine Follow-Up for Early Medical Abortion
High fever following postpartum administration of sublingual misoprostol
What measured blood loss tells us about postpartum bleeding
Misoprostol as adjunct treatment for treatment of postpartum haemorrhage
Unsafe Abortion and Strategies to Reduce its Impact on Women’s Lives
Sublingual misoprostol vs. MVA for the treatment of incomplete abortion in Egypt
Self-induction of abortion among women in the United States
Buccal vs. sublingual misoprostol after mifepristone for medical abortion
Oral misoprostol as an alternative to surgical management for incomplete abortion in Ghana
Ultrasound for eligibility assessment for medical abortion
Comparing two early medical abortion regimens: Mifepristone+misoprostol vs. misoprostol alone
Introduction and provision of medical abortion: A tale of two countries
Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-trimester Abortion
Review of the Literature on Patient Satisfaction with Early Medical Abortion
Oral Misoprostol for the Management of Incomplete Abortion in Ecuador
Misoprostol as adjunct treatment for treatment of postpartum haemorrhage
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2/2
Alternatives to mifepristone for early medical abortion
Misoprostol, Abortion, and the Law
Non-physician clinicians can safely provide first trimester medical abortion
Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan
Misoprostol for PPH prevention in homebirths in Pakistan
Perspectives on reproductive decision-making amongst HIV-infected individuals